Announced Fri, 10 Jul · 13:09 IST
Aurobindo Pharma incorporates new step-down subsidiary in Indonesia
Strategic Transactions View source PDF
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹1582.70
prior close
₹1563.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.0-0.0+0.0-2.2-1.9-2.2-2.1-3.0+0.1————
Up moveDown movePending
AI summary
Aurobindo Pharma's step-down subsidiary PT Aurogen Pharma Indonesia has set up a new wholly owned arm, PT Auro Pharm Indonesia, incorporated on July 1, 2026 with incorporation approval on July 9. The new entity will undertake pharmaceutical manufacturing operations in Indonesia. Initial capital is IDR 20 billion (2000 shares of IDR 10 million each), paid fully in cash. Promoters have no direct interest, and no regulatory approvals are needed.
Likely market impact
Sets up Indonesia manufacturing arm, supporting Aurobindo's global pharma expansion. Small deal; no near-term material financial impact.